-
1 Comment
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd is currently in a long term uptrend where the price is trading 1.9% above its 200 day moving average.
From a valuation standpoint, the stock is 55.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.3.
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's total revenue sank by 31.0% to $49M since the same quarter in the previous year.
Its net income has dropped by 26.2% to $-2M since the same quarter in the previous year.
Finally, its free cash flow fell by 656.8% to $-16M since the same quarter in the previous year.
Based on the above factors, Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd gets an overall score of 2/5.
ISIN | CNE000000BF3 |
---|---|
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Exchange | SHG |
CurrencyCode | CNY |
Market Cap | 2B |
---|---|
PE Ratio | 112.46 |
Target Price | None |
Beta | 0.18 |
Dividend Yield | None |
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces and sells medicines and related health care products, including tablets, granules, pills, mixtures, oral liquids, syrups, eye drops, pills, soft capsules, tablets, granules, and other health foods. It is also involved in the sale of menthol and peppermint oil raw materials, Chinese medicine formulas, Chinese medicine pieces, fresh herbs, etc.; and provision of professional medical services, such as valet decoction and distribution, as well as Chinese medicine diagnosis and treatment services. In addition, the company engages in the software development, remote health management, commercial complex management, food, Internet information businesses, etc. The company was founded in 1958 and is headquartered in Hangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600671.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025